Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1919 1
1950 2
1952 1
1953 5
1954 1
1955 2
1956 1
1957 3
1958 3
1959 6
1960 1
1961 9
1962 12
1963 10
1964 10
1965 10
1966 12
1967 10
1968 12
1969 11
1970 30
1971 35
1972 24
1973 34
1974 45
1975 29
1976 30
1977 26
1978 52
1979 43
1980 43
1981 37
1982 69
1983 78
1984 75
1985 73
1986 89
1987 85
1988 114
1989 135
1990 121
1991 113
1992 139
1993 110
1994 132
1995 149
1996 129
1997 165
1998 135
1999 179
2000 188
2001 174
2002 236
2003 270
2004 233
2005 281
2006 299
2007 261
2008 287
2009 272
2010 329
2011 334
2012 381
2013 364
2014 355
2015 363
2016 415
2017 385
2018 420
2019 436
2020 496
2021 528
2022 486
2023 468
2024 489
2025 242

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,531 results

Results by year

Filters applied: . Clear all
Page 1
Clinical management, monitoring, and prophylaxis of adverse events of special interest associated with datopotamab deruxtecan.
Heist RS, Sands J, Bardia A, Shimizu T, Lisberg A, Krop I, Yamamoto N, Kogawa T, Al-Hashimi S, Fung SSM, Galor A, Pisetzky F, Basak P, Lau C, Meric-Bernstam F. Heist RS, et al. Among authors: shimizu t. Cancer Treat Rev. 2024 Apr;125:102720. doi: 10.1016/j.ctrv.2024.102720. Epub 2024 Mar 11. Cancer Treat Rev. 2024. PMID: 38502995 Free article. Review.
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2- and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study.
Bardia A, Krop IE, Kogawa T, Juric D, Tolcher AW, Hamilton EP, Mukohara T, Lisberg A, Shimizu T, Spira AI, Tsurutani J, Damodaran S, Papadopoulos KP, Greenberg J, Kobayashi F, Zebger-Gong H, Wong R, Kawasaki Y, Nakamura T, Meric-Bernstam F. Bardia A, et al. Among authors: shimizu t. J Clin Oncol. 2024 Jul 1;42(19):2281-2294. doi: 10.1200/JCO.23.01909. Epub 2024 Apr 23. J Clin Oncol. 2024. PMID: 38652877 Free PMC article. Clinical Trial.
Gastrite phlegmoneuse.
Kakimoto S, Harada Y, Shimizu T. Kakimoto S, et al. Among authors: shimizu t. CMAJ. 2023 Nov 14;195(44):E1525-E1526. doi: 10.1503/cmaj.230767-f. CMAJ. 2023. PMID: 37963625 Free PMC article. French. No abstract available.
Kommerell's Diverticulum.
Kakimoto S, Harada Y, Shimizu T. Kakimoto S, et al. Among authors: shimizu t. J Gen Intern Med. 2024 May;39(7):1264-1265. doi: 10.1007/s11606-024-08672-3. Epub 2024 Feb 12. J Gen Intern Med. 2024. PMID: 38347347 Free PMC article. No abstract available.
Lupus Vulgaris.
Kakimoto S, Harada Y, Shimizu T. Kakimoto S, et al. Among authors: shimizu t. Am J Med. 2025 Apr;138(4):e57. doi: 10.1016/j.amjmed.2024.11.028. Epub 2024 Nov 30. Am J Med. 2025. PMID: 39617114 No abstract available.
Cathepsin C inhibition reduces neutrophil serine protease activity and improves activated neutrophil-mediated disorders.
Nishibata Y, Arai S, Taniguchi M, Nakade I, Ogawa H, Kitano S, Hosoi Y, Shindo A, Nishiyama R, Masuda S, Nakazawa D, Tomaru U, Shimizu T, Sinko W, Nagakura T, Terada Y, Ishizu A. Nishibata Y, et al. Among authors: shimizu t. Nat Commun. 2024 Aug 22;15(1):6519. doi: 10.1038/s41467-024-50747-6. Nat Commun. 2024. PMID: 39174512 Free PMC article.
Black pleural effusion.
Kakimoto S, Harada Y, Shimizu T. Kakimoto S, et al. Among authors: shimizu t. QJM. 2025 Apr 1;118(4):282-283. doi: 10.1093/qjmed/hcae210. QJM. 2025. PMID: 39475438 No abstract available.
10,531 results
You have reached the last available page of results. Please see the User Guide for more information.